Pharmacokinetics of single and multiple doses of phenytoin in man

[1]  B. Alexanderson.  Pharmacokinetics of nortriptyline in man after single and multiple oral doses: The predictability of steady-state plasma concentrations from single-dose plasma-level data , 1972, European Journal of Clinical Pharmacology.

[2]  O. Borgå,et al.  Kinetics of diphenylhydantoin in uraemic patients: Consequences of decreased plasma protein binding , 2004, European Journal of Clinical Pharmacology.

[3]  J. Wagner,et al.  Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation. , 1972, Research communications in chemical pathology and pharmacology.

[4]  F. Sjöqvist,et al.  Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method. , 1972, Scandinavian journal of clinical and laboratory investigation.

[5]  W. L. Weller,et al.  Study of dose-dependent metabolism of 5,5-diphenyl-hydantoin in the rat using new methodology for isolation and quantitation of metabolites in vivo and in vitro. , 1971, The Journal of pharmacology and experimental therapeutics.

[6]  C. Bahr,et al.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. , 1971, The New England journal of medicine.

[7]  L. Skovsted,et al.  Carbamazepine‐induced acceleration of diphenylhydantoin and warfarin metabolism in man , 1971, Clinical pharmacology and therapeutics.

[8]  F. Sjöqvist.  A pharmacokinetic approach to the treatment of depression. , 1971, International pharmacopsychiatry.

[9]  P. K. Lunde,et al.  Plasma protein binding of diphenylhydantoin in man. , 1971, Acta pharmacologica et toxicologica.

[10]  M. Eadie,et al.  Outbreak of Anticonvulsant Intoxication in an Australian City* , 1970, British medical journal.

[11]  A. Handley,et al.  Supervision of Epileptic Patients Taking Phenytoin , 1970, British medical journal.

[12]  K. Arnold,et al.  The rate of decline of diphenylhydantoin in human plasma , 1970, Clinical pharmacology and therapeutics.

[13]  G. Levy,et al.  ABSORPTION AND DISSOLUTION STUDIES ON DIPHENYLHYDANTOIN CAPSULES , 1970 .

[14]  H. Remmer,et al.  [The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)]. , 1969, Deutsche medizinische Wochenschrift.

[15]  H. Kutt,et al.  Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients. , 1968, JAMA.

[16]  M. Kristensen,et al.  Sulthiame (Ospolot®) as Inhibitor of Diphenylhydantoin Metabolism , 1968, Epilepsia.

[17]  M. Weiss,et al.  Dose-dependence of drug plasma level decline in dogs. , 1967, The Journal of pharmacology and experimental therapeutics.

[18]  H. M. Solomon,et al.  The effect of phenyramidol on the metabolism of diphenylhydantoin , 1967, Clinical pharmacology and therapeutics.

[19]  O. Olesen.  The influence of disulfiram and calcium carbimide on the serum diphenylhydantoin. Excretion of HPPH in the urine. , 1967, Archives of neurology.

[20]  M. Kristensen,et al.  Dicoumarol-induced diphenylhydantoin intoxication. , 1966, Lancet.

[21]  F. Mcdowell,et al.  Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy , 1966, Neurology.

[22]  J. Wagner,et al.  Blood Levels of Drug at the Equilibrium State after Multiple Dosing , 1965, Nature.

[23]  H. Kutt,et al.  DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY. , 1964, Archives of neurology.

[24]  F. Mcdowell,et al.  Insufficient parahydroxylation as a cause of diphenylhydantoin toxicity , 1964, Neurology.

[25]  M. Lund,et al.  Serum Diphenylhydantoin (Phenytoin) in Ambulant Patients with Epilepsy , 1964, Epilepsia.

[26]  F. Buchthal,et al.  Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. , 1960, Archives of neurology.

[27]  F. Buchthal,et al.  Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. , 1960, Archives of neurology.

[28]  A. Glazko,et al.  Studies on 5, 5'-diphenylhydantoin (dilantin) in animals and man. , 1956, The Journal of pharmacology and experimental therapeutics.